An interventional study of Control and High dairy protein in Insulin and Glucose Metabolism, sponsored by Maastricht University Medical Center. Completed. Open to male participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-08-23.
Sponsored by Maastricht University Medical Center · Not applicable, Interventional, and Prevention
The purpose of this study is to determine whether different protein diets affects glucose and insulin metabolism and substrate partitioning.
Maastricht University Medical Center is the lead sponsor of 835 studies on the registry; 122 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Diet consists of 15% dairy protein and low Glycemic Index (GI \< 40), 55 En% carbohydrates and 30 En% fat
Dietary Supplement: Control
Diet consists of 25% dairy protein and low GI (GI \< 40), 45 En% carbohydrates and 30 En% fat
Dietary Supplement: High dairy protein
Diet consists of 15 En% vegetable protein and low GI (GI \< 40), 55 En% carbohydrates and 30 En% fat
Dietary Supplement: vegetable protein
Diet consists of 15 En% dairy protein and high GI(GI \> 60, 55 En% carbohydrates and 30 En% fat
Dietary Supplement: High GI
Diet consists of 15 En% dairy protein and low GI, 55 En% carbohydrates and 30 En% fat
Diet consists of 25 En% dairy protein and low GI, 55 En% carbohydrates and 30 En% fat
Diet consists of 15 En% vegetable protein and low GI, 55 En% carbohydrates and 30 En% fat
Diet consists of 15 En% dairy protein and high GI, 55 En% carbohydrates and 30 En% fat
Glucose and insulin metabolism (24 h)
Time frame: 24 h
Substrate partitioning and metabolic markers
Time frame: 24 h
No study locations are listed for this record.
This study is completed, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Maastricht University Medical Center